Schering-Plough announces Pfizer closing
Schering-Plough has announced the successful closing of its previously
announced transaction with Pfizer Animal Health, to divest certain animal health
products from selected franchises in the European Economic Area to
With this announcement, Schering-Plough has now successfully completed all
product divestments required by the commitments made to the European Commission
in connection with its approval of its acquisition of Organon Biosciences in
Transaction an important step
"We are making good progress both globally and at the country level on our
integration, and the closing of the transaction with Pfizer is another very
important step in both that process, as well as fulfilling our
acquisition-related commitments to the European Commission," said Ruurd Stolp,
President of Intervet/Schering-Plough Animal Health.
This agreement does not affect Intervet/Schering-Plough Animal Health's
marketing of these products in other global markets beyond Europe.
To comment, login here
Or register to be able to comment.